Terms: = Liver cancer AND MEN1, ENSG00000133895, 4221
146 results:
1. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
2. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
3. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract] [Full Text] [Related]
4. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
5. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
[TBL] [Abstract] [Full Text] [Related]
6. Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract] [Full Text] [Related]
7. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
[TBL] [Abstract] [Full Text] [Related]
8. Hypersensitivity Reactions to Transarterial Chemoembolization with Cisplatin and Ethiodized Oil: A Retrospective Cohort Study.
Kwok TW; Wong SM; Yu CH; Young WM
J Vasc Interv Radiol; 2023 May; 34(5):799-806.e2. PubMed ID: 36584810
[TBL] [Abstract] [Full Text] [Related]
9. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
[TBL] [Abstract] [Full Text] [Related]
10. Pitfalls in the Diagnosis of Primary Hyperparathyroidism in a Sudanese Adolescent Boy; a case disguised as rickets.
Gafar SM; Fadlalbari GF; Abdalla AT; Mohammed SAR; Alrasheed MK; Taha IA; Abdullah MA
BMC Endocr Disord; 2022 Dec; 22(1):322. PubMed ID: 36529731
[TBL] [Abstract] [Full Text] [Related]
11. Sporadic and men1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms.
Liu JB; Cai J; Dhir M; Paniccia A; Zureikat AH; Ramonell KM; McCoy KL; Carty SE; Yip L
Ann Surg Oncol; 2022 Nov; 29(12):7808-7817. PubMed ID: 35963905
[TBL] [Abstract] [Full Text] [Related]
13. Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study.
Gaujoux S; Martin GL; Mirallié E; Regenet N; Le Bras M; Pattou F; Carnaille B; Cardot-Bauters C; Groussin L; Faron M; Chanson P; Najah H; Tabarin A; Sauvanet A; Ruszniewski P; Lifante JC; Walter T; Carrère N; Caron P; Deguelte S; Delemer B; Binquet C; Jannot AS; Goudet P
Br J Surg; 2022 Aug; 109(9):872-879. PubMed ID: 35833229
[TBL] [Abstract] [Full Text] [Related]
14. High-grade transformation of pancreatic neuroendocrine tumor associated with TP53 mutations: A diagnostic pitfall mimicking neuroendocrine carcinoma.
Tanaka M; Shinozaki-Ushiku A; Kunita A; Yasunaga Y; Akamatsu N; Hasegawa K; Ushiku T
Pathol Int; 2022 Aug; 72(8):411-418. PubMed ID: 35698921
[TBL] [Abstract] [Full Text] [Related]
15. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
16. Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.
Raj N; Coffman K; Le T; Do RKG; Rafailov J; Choi Y; Chou JF; Capanu M; Dunphy M; Fox JJ; Grewal RK; Reddy RP; Riedl C; Schoder H; Bodei L; Reidy-Lagunes D
Neuroendocrinology; 2022; 112(12):1177-1186. PubMed ID: 35609558
[TBL] [Abstract] [Full Text] [Related]
17. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract] [Full Text] [Related]
18. Gastric neuroendocrine neoplasms: a primer for radiologists.
Roseland ME; Francis IR; Shampain KL; Stein EB; Wasnik AP; Millet JD
Abdom Radiol (NY); 2022 Dec; 47(12):3993-4004. PubMed ID: 35411433
[TBL] [Abstract] [Full Text] [Related]
19. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
20. 68Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated Adrenocortical Carcinoma.
Basheer S; Ratheesan R; Sarma M; Palaniswamy SS; Mathews A
Clin Nucl Med; 2022 May; 47(5):e389-e392. PubMed ID: 35195585
[TBL] [Abstract] [Full Text] [Related]
[Next]